A day after highlighting the challenges in India’s plan for the production and distribution of the Covid-19 vaccine, Adar Poonawalla, CEO of the local vaccine maker Serum Institute of India (SII), took to Twitter to praise the first. Minister Narendra Modi for his speech at the United Nations General Assembly …
Read More »
One day after asking if the government will have ₹80,000 crore available to purchase and distribute the vaccine, Adar Poonawalla, executive director of the Serum Institute of India, took to Twitter today to praise Prime Minister Narendra Modi’s speech at the United Nations General Assembly on Covid-19 vaccines. We share …
Read More »
Adar Poonawalla, executive director of the Serum Institute of India which is conducting trials of Covid-19 vaccine candidates, raised questions on Saturday about the country’s plan to produce and distribute injections against the coronavirus disease. A phase III trial of the vaccine candidate developed by the University of Oxford and …
Read More »
NEW DELHI: No vaccine for respiratory diseases it is 100% effective and those that are 50-100% effective can be approved for use against the Covid-19 pandemic, Indian Council of Medical Research (ICMR), Dr. Balram Bhargava, CEO, said even when adding that maximum efficacy will be sought. “No vaccine for respiratory …
Read More »
NEW DELHI: Codagenix Inc said Tuesday that the Serum Institute of India has started manufacturing the potential Covid-19 vaccine from the American biotech company and expects to begin early-stage human testing of the vaccine by the end of 2020 in the UK. United. Serum Institute, the world’s largest vaccine manufacturer …
Read More »
A vaccine for the coronavirus is likely to be ready in early 2021, but safely deploying it to India’s 1.3 billion people will be the country’s biggest challenge in fighting its growing epidemic, a leading vaccine scientist told Bloomberg. India, which is home to some of the cutting-edge vaccine clinical …
Read More »
The phase III human clinical trial of the Covid-19 vaccine being developed by the University of Oxford and manufactured by the Serum Institute of India (SII), began at the state-run Sassoon General Hospital here in Maharashtra, El Monday, a senior official said. . “We have started phase III trials of …
Read More »
PUNE: The Phase III human clinical trial of the Covid-19 vaccine being developed by the University of Oxford and manufactured by the Serum Institute of India (SII), began at the state-run Sassoon General Hospital here in Maharashtra On Monday, a senior official said. “We have started phase III trials of …
Read More »
The central government informed the Lok Sabha on Friday that India is in contact with Russia to advance trials of the COVID-19 vaccine – Sputnik V – in the country, according to the news agency. PTI. India is “exploring the possibility of cooperation between the two countries to promote the …
Read More »
Covid vaccine: DCGI has allowed Serum Institute to restart its phase two and three clinical trials New Delhi: Latest Coronavirus Updates: India’s COVID-19 case count has crossed the 50 lakh mark with an increase of 90,123 new cases and 1,290 deaths, the highest the country has seen in 24 hours, …
Read More »